MEREO BIOPHARMA GROUP PL-ADR
MREONASDAQ🏆 #3678 by market capEarnings Nov 9US Equity
$0.31▲ $0.04 (+12.15%)
Market closed · at close1h—
24h▲ 12.2%
7d▲ 0.6%
14d▼ 0.6%
30d▼ 4.6%
1y▼ 81.6%
🏦Market Cap
$49M
Small Cap
📈Revenue Growth (YoY)
+0.0%
Slowing
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
55
Weak
📊
Analyst Ratings
Price
$0.3055
Total
8
Raised
0
Lowered
3
Avg PT
$3.25
H / L
$8 / $1
| Institution | Action | Rating | Date |
|---|---|---|---|
BTIG | Reiterated | Buy | 2026-05-12 |
JP Morgan | Downgraded | Overweight → Neutral | 2026-03-23 |
Needham | Reiterated | Buy | 2026-01-13 |
Jefferies | Downgraded | Buy → Hold | 2025-12-30 |
LifeSci Capital | Downgraded | Outperform → Market Perform | 2025-12-29 |
Cantor Fitzgerald | Reiterated | Overweight | 2025-03-18 |
Leerink Partners | Reiterated | Outperform | 2024-06-20 |
SVB Leerink | Reiterated | Outperform | 2022-11-10 |
One row per institution, most recent rating